Skip to main content
Erschienen in: Current Allergy and Asthma Reports 2/2016

01.02.2016 | Anaphylaxis and Drug Allergy (DA Khan and M Castells, Section Editors)

Rapid Aspirin Challenge in Patients with Aspirin Allergy and Acute Coronary Syndromes

verfasst von: Kevin A. Cook, Andrew A. White

Erschienen in: Current Allergy and Asthma Reports | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Aspirin allergy in a patient with acute coronary syndrome represents one of the more urgent challenges an allergist may face. Adverse reactions to aspirin are reported in 1.5 % of patients with coronary artery disease. A history of adverse reaction to aspirin often leads to unnecessary withholding of this medication or use of alternative antiplatelet therapy which may be inferior or more costly. Aspirin therapy has been shown to reduce morbidity and mortality in patients with coronary artery disease. Rapid aspirin challenge/desensitization in the aspirin allergic patient has been consistently shown to be both safe and successful in patients with acute coronary syndromes.
Literatur
1.
Zurück zum Zitat Amsterdam EA et al. 2014 ACC/AHA guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:2354–94.CrossRefPubMed Amsterdam EA et al. 2014 ACC/AHA guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:2354–94.CrossRefPubMed
2.
Zurück zum Zitat Wong JT, Nagy CS, Krinzman SJ, et al. Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema. J Allergy Clin Immunol. 2000;105:997–1001.CrossRefPubMed Wong JT, Nagy CS, Krinzman SJ, et al. Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema. J Allergy Clin Immunol. 2000;105:997–1001.CrossRefPubMed
3.
Zurück zum Zitat De Luca G, Verdoia M, Binda G, et al. Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience. Int J Cardiol. 2013;167(2):561–3.CrossRefPubMed De Luca G, Verdoia M, Binda G, et al. Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience. Int J Cardiol. 2013;167(2):561–3.CrossRefPubMed
4.
Zurück zum Zitat McMullan KL, Wedner HJ. Safety of aspirin desensitization in patients with reported aspirin allergy and cardiovascular disease. Clin Cardiol. 2013;36:25–30.CrossRefPubMed McMullan KL, Wedner HJ. Safety of aspirin desensitization in patients with reported aspirin allergy and cardiovascular disease. Clin Cardiol. 2013;36:25–30.CrossRefPubMed
5.
Zurück zum Zitat Rossini R, Angiolillo DJ, Musumeci G, et al. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation. Am J Cardiol. 2008;101:786–9.CrossRefPubMed Rossini R, Angiolillo DJ, Musumeci G, et al. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation. Am J Cardiol. 2008;101:786–9.CrossRefPubMed
6.
Zurück zum Zitat Silberman S, Neukirch-Stoop C, Steg PG. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting. Am J Cardiol. 2005;95:509–10.CrossRefPubMed Silberman S, Neukirch-Stoop C, Steg PG. Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting. Am J Cardiol. 2005;95:509–10.CrossRefPubMed
7.
Zurück zum Zitat Fajt ML, Petrov AA. Outpatient aspirin desensitization for patients with aspirin hypersensitivity and cardiac disease. Crit Pathw Cardiol. 2011;10:17–21.CrossRefPubMed Fajt ML, Petrov AA. Outpatient aspirin desensitization for patients with aspirin hypersensitivity and cardiac disease. Crit Pathw Cardiol. 2011;10:17–21.CrossRefPubMed
8.
Zurück zum Zitat Cortellini G, Testi S, Severino M, et al. Aspirin challenge/desensitisation before coronary stenting in subjects with history of hypersensitivity. A pragmatic approach. Eur Ann Allergy Clin Immunol. 2012;44(4):160–2.PubMed Cortellini G, Testi S, Severino M, et al. Aspirin challenge/desensitisation before coronary stenting in subjects with history of hypersensitivity. A pragmatic approach. Eur Ann Allergy Clin Immunol. 2012;44(4):160–2.PubMed
9.
Zurück zum Zitat Dalmau G, Gaig P, Gazquez V, Merce J. Rapid desensitization to acetylsalicylic acid in acute coronary syndrome patients with NSAID intolerance. Rev Esp Cardiol. 2009;62:224–5.CrossRefPubMed Dalmau G, Gaig P, Gazquez V, Merce J. Rapid desensitization to acetylsalicylic acid in acute coronary syndrome patients with NSAID intolerance. Rev Esp Cardiol. 2009;62:224–5.CrossRefPubMed
10.
Zurück zum Zitat Ortega-Loayza AG, Raza S, Minisi AJ, et al. Aspirin desensitization/challenge in 3 patients with unstable angina. Am J Med Sci. 2010;340:418–20.CrossRefPubMed Ortega-Loayza AG, Raza S, Minisi AJ, et al. Aspirin desensitization/challenge in 3 patients with unstable angina. Am J Med Sci. 2010;340:418–20.CrossRefPubMed
11.
Zurück zum Zitat Christou A, Kafkas N, Marinakos A, et al. Rapid desensitisation of patients with aspirin allergy who undergo coronary angioplasty. Hell J Cardiol. 2011;52(4):307–10. Christou A, Kafkas N, Marinakos A, et al. Rapid desensitisation of patients with aspirin allergy who undergo coronary angioplasty. Hell J Cardiol. 2011;52(4):307–10.
12.
Zurück zum Zitat Jenneck C, Juergens U, Buecheler M, Novak N. Pathogenesis, diagnosis, and treatment of aspirin intolerance. Ann Allergy Asthma Immunol. 2007;99:13e21.CrossRef Jenneck C, Juergens U, Buecheler M, Novak N. Pathogenesis, diagnosis, and treatment of aspirin intolerance. Ann Allergy Asthma Immunol. 2007;99:13e21.CrossRef
13.•
Zurück zum Zitat Feng CH, White AA, Stevenson DD. Characterization of aspirin allergies in patients with coronary artery disease. Ann Allergy Asthma Immunol. 2013;110(2):92–5. This article reviews 9,565 patients who were identified in a medical record with CAD and aspirin listed as an “allergy”. The article reports the nature of these reactions and also highlights the underutilization of aspirin challenge/desensitization.CrossRefPubMed Feng CH, White AA, Stevenson DD. Characterization of aspirin allergies in patients with coronary artery disease. Ann Allergy Asthma Immunol. 2013;110(2):92–5. This article reviews 9,565 patients who were identified in a medical record with CAD and aspirin listed as an “allergy”. The article reports the nature of these reactions and also highlights the underutilization of aspirin challenge/desensitization.CrossRefPubMed
14.
Zurück zum Zitat Meyboom RHB, Lindquist M, Egberts ACG. An ABC of drug related problems. Drug Saf. 2000;22:415–23.CrossRefPubMed Meyboom RHB, Lindquist M, Egberts ACG. An ABC of drug related problems. Drug Saf. 2000;22:415–23.CrossRefPubMed
15.
Zurück zum Zitat Gollapudi RR, Teirstein PS, Stevenson DD, Simon RA. Aspirin sensitivity: implications for patients with coronary artery disease. JAMA. 2004;292:3017e3023.CrossRef Gollapudi RR, Teirstein PS, Stevenson DD, Simon RA. Aspirin sensitivity: implications for patients with coronary artery disease. JAMA. 2004;292:3017e3023.CrossRef
16.•
Zurück zum Zitat Kowalski ML, Asero R, Bavbek S, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 2013;68:1219–32. A comprehensive review describing the various hypersensitivity syndromes associated with aspirin and NSAIDs. Proposed diagnostic evaluation is also described.CrossRefPubMed Kowalski ML, Asero R, Bavbek S, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 2013;68:1219–32. A comprehensive review describing the various hypersensitivity syndromes associated with aspirin and NSAIDs. Proposed diagnostic evaluation is also described.CrossRefPubMed
17.
Zurück zum Zitat Rajan JP, Wineinger NE, Stevenson DD, White AA. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. J Allergy Clin Immunol. 2015;135(3):676.CrossRefPubMed Rajan JP, Wineinger NE, Stevenson DD, White AA. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. J Allergy Clin Immunol. 2015;135(3):676.CrossRefPubMed
18.
Zurück zum Zitat Mastalerz L, Setkowicz M, Szczeklik A. Mechanism of chronic urticaria exacerbation by aspirin. Curr Allergy Asthma Rep. 2005;5(4):277–83.CrossRefPubMed Mastalerz L, Setkowicz M, Szczeklik A. Mechanism of chronic urticaria exacerbation by aspirin. Curr Allergy Asthma Rep. 2005;5(4):277–83.CrossRefPubMed
19.
Zurück zum Zitat Woessner KM. Aspirin desensitization for cardiovascular disease. Curr Opin Allergy Clin Immunol. 2015;15(4):314–22.CrossRefPubMed Woessner KM. Aspirin desensitization for cardiovascular disease. Curr Opin Allergy Clin Immunol. 2015;15(4):314–22.CrossRefPubMed
20.
Zurück zum Zitat Katz Y, Goldberg N, Kivity S. Localized periorbital edema induced by aspirin. Allergy. 1993;48:366–9.CrossRefPubMed Katz Y, Goldberg N, Kivity S. Localized periorbital edema induced by aspirin. Allergy. 1993;48:366–9.CrossRefPubMed
21.
Zurück zum Zitat Leeyaphan C, Kulthanan K, Jongjarearnprasert K, Dhana N. Drug-induced angioedema without urticaria: prevalence and clinical features. J Eur Acad Dermatol Venereol. 2010;24:685–91.CrossRefPubMed Leeyaphan C, Kulthanan K, Jongjarearnprasert K, Dhana N. Drug-induced angioedema without urticaria: prevalence and clinical features. J Eur Acad Dermatol Venereol. 2010;24:685–91.CrossRefPubMed
22.
Zurück zum Zitat Himly M, Jahn-Schmid B, Pittertschatscher K, Bohle B, Grubmayr K, Ferreira F, et al. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol. 2003;111:882–8.CrossRefPubMed Himly M, Jahn-Schmid B, Pittertschatscher K, Bohle B, Grubmayr K, Ferreira F, et al. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol. 2003;111:882–8.CrossRefPubMed
23.
Zurück zum Zitat Phills J, Perelmutter L. IgE and non-IgE mediated allergic-type reactions to aspirin. Acta Allergol. 1974;29:474–9.CrossRefPubMed Phills J, Perelmutter L. IgE and non-IgE mediated allergic-type reactions to aspirin. Acta Allergol. 1974;29:474–9.CrossRefPubMed
24.
Zurück zum Zitat Blanca M, Perez E, Garcia JJ, et al. Angioedema and IgE antibodies to aspirin: a case report. Ann Allergy. 1989;62:295–8.PubMed Blanca M, Perez E, Garcia JJ, et al. Angioedema and IgE antibodies to aspirin: a case report. Ann Allergy. 1989;62:295–8.PubMed
25.•
Zurück zum Zitat Aun MV, Blana M, Garro LS, et al. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol. 2014;2:414–20. A review of anaphylaxis caused by medications. In this review NSAIDs are noted to be the most frequent cause of anaphylaxis in patients presenting to the emergency department with a drug reaction. The article also reports an underutilization of epinephrine in patients presenting with anaphylaxis.CrossRef Aun MV, Blana M, Garro LS, et al. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol. 2014;2:414–20. A review of anaphylaxis caused by medications. In this review NSAIDs are noted to be the most frequent cause of anaphylaxis in patients presenting to the emergency department with a drug reaction. The article also reports an underutilization of epinephrine in patients presenting with anaphylaxis.CrossRef
26.
Zurück zum Zitat Ward KE, Archambault R, Mersfelder TL. Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: a review of the literature. Am J Health Syst Pharm. 2010;67(3):206–13.CrossRefPubMed Ward KE, Archambault R, Mersfelder TL. Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: a review of the literature. Am J Health Syst Pharm. 2010;67(3):206–13.CrossRefPubMed
27.
Zurück zum Zitat Aseros R. Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs. Clin Exp Allergy. 2005;35:713–6.CrossRef Aseros R. Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs. Clin Exp Allergy. 2005;35:713–6.CrossRef
28.
Zurück zum Zitat The CURRENT–OASIS 7 Investigators. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med. 2010;363:10.CrossRef The CURRENT–OASIS 7 Investigators. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med. 2010;363:10.CrossRef
29.
Zurück zum Zitat Anderson JL, Adams CD, Antman EM. 2011 ACCF/AHA focused update on the management of patients with unstable angina/non-ST-elevation myocardial infarction. Circulation. 2011;123:2022–60.CrossRefPubMed Anderson JL, Adams CD, Antman EM. 2011 ACCF/AHA focused update on the management of patients with unstable angina/non-ST-elevation myocardial infarction. Circulation. 2011;123:2022–60.CrossRefPubMed
30.
Zurück zum Zitat Kern M. Conversations in cardiology: what to do if your patient can’t take aspirin after stenting. Cath Lab Digest. 2014;22:10. Kern M. Conversations in cardiology: what to do if your patient can’t take aspirin after stenting. Cath Lab Digest. 2014;22:10.
Metadaten
Titel
Rapid Aspirin Challenge in Patients with Aspirin Allergy and Acute Coronary Syndromes
verfasst von
Kevin A. Cook
Andrew A. White
Publikationsdatum
01.02.2016
Verlag
Springer US
Erschienen in
Current Allergy and Asthma Reports / Ausgabe 2/2016
Print ISSN: 1529-7322
Elektronische ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-015-0593-2

Weitere Artikel der Ausgabe 2/2016

Current Allergy and Asthma Reports 2/2016 Zur Ausgabe

Rhinosinusitis (J Mullol, Section Editor)

Risk Factors and Comorbidities in Chronic Rhinosinusitis

Immune Deficiency and Dysregulation (DP Houston and C Kuo, Section Editors)

Immune-Microbiota Interactions: Dysbiosis as a Global Health Issue

Allergens (RK Bush and JA Woodfolk, Section Editors)

The Immunologic Mechanisms of Eosinophilic Esophagitis

Allergens (RK Bush and JA Woodfolk, Section Editors)

T Cell Epitope Peptide Therapy for Allergic Diseases

Rhinitis (JJ Oppenheimer and J Corren, Section Editors)

Understanding Biofilms in Chronic Sinusitis

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.